Hjem › Ikke-småcellet lungekreft › Florida › Sarasota
Kliniske studier for Ikke-småcellet lungekreft i Sarasota, FL
17 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Sarasota (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
RekruttererFase 1
- Florida Cancer Specialists, Sarasota
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
RekruttererFase 1
- Florida Cancer Specialists & Research Institute - Sarasota Cattlemen, Sarasota
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruttererFase 3
- Florida Cancer Specialists, Sarasota
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- Florida Cancer Specialists, Sarasota
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RekruttererFase 1/2
- Florida Cancer Specialists & Research Institute - Sarasota, Sarasota
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekruttererFase 2/3
- Local Institution - 007-922-I, Sarasota
- Local Institution - 007-922-J, Sarasota
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
RekruttererFase 1/2
- Florida Cancer Specialists, Sarasota
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- Florida Cancer Specalists, Sarasota
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
RekruttererFase 1
- Florida Cancer Specialists - Sarasota, Sarasota
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
RekruttererFase 1
- Florida Cancer Specialists, Sarasota
A Study of LY4175408 in Participants With Advanced Cancer
RekruttererFase 1
- Florida Cancer Specialists - Sarasota, Sarasota
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RekruttererFase 1
- Florida Cancer Specialists, Sarasota
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
RekruttererFase 1
- Florida Cancer Specialists, Sarasota
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekruttererFase 1
- Florida Cancer Specialists, Sarasota
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
RekruttererFase 1/2
- Florida Cancer Specialists, Sarasota
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- Florida Cancer Specialists, Sarasota
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekruttererFase 1
- Dren Investigational Site, Sarasota
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andre studier i Sarasota
- Metastatisk kreft19 studier
- Kolorektal kreft16 studier
- Eggstokkreft16 studier
- Endometriekreft14 studier
- Brystkreft12 studier
- Kreft (alle typer)11 studier
- Tripelnegativ brystkreft8 studier
- Lungekreft7 studier
- Pankreaskreft7 studier
- Atrieflimmer7 studier
- Prostatakreft6 studier
- Steatotisk leversykdom6 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.